Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW +1.52% shed 2.05% to $115.83 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.02% falling 1.84% to 4,577.11 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.34% falling 1.51% to 35,368.47. This was the stock's third consecutive day of losses. Edwards Lifesciences Corp. closed $15.90 below its 52-week high ($131.73), which the company achieved on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT +2.36% fell 0.98% to $107.49, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX +3.77% fell 1.43% to $44.22, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI +2.79% fell 2.28% to $214.98. Trading volume (2.6 M) eclipsed its 50-day average volume of 2.3 M.